Intellia Therapeutics NTLA
$ 13.89
5.87%
Quarterly report 2024-Q3
added 11-07-2024
Intellia Therapeutics EV/EBITDA Ratio 2011-2024 | NTLA
Annual EV/EBITDA Ratio Intellia Therapeutics
2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
---|---|---|---|---|---|---|---|---|---|---|
0.447 | -25.7 | -5.33 | -6.18 | -8.94 | -0.195 | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
Maximum | Minimum | Average |
---|---|---|
0.447 | -25.7 | -7.64 |